Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer

Pengying Wu; Dongtao Yin; Jiaming Liu; Huige Zhou; Mengyu Guo; Jing Liu; Yang Liu; Xiaobing Wang; Ying Liu; Chunying Chen

doi:10.1039/D2NR90232J

Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer

Pengying Wu,^ab Dongtao Yin,^cd Jiaming Liu,^a Huige Zhou,^a Mengyu Guo,^a Jing Liu,^ae Yang Liu,^c Xiaobing Wang,*^b Ying Liu*^a and Chunying Chen*^a

Author affiliations

* Corresponding authors

^a CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China
E-mail: chenchy@nanoctr.cn, liuy@nanoctr.cn

^b Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, China
E-mail: wangxiaobing@snnu.edu.cn

^c Department of Thoracic Surgery, General Hospital of the Chinese People's Liberation Army, Beijing 100853, China

^d Department of Thoracic Surgery, Rocket Force Characteristic Medical Center of the Chinese People's Liberation Army, Beijing 100088, China

^e The College of Life Sciences, Northwest University, Xi'an 710069, China

Abstract

Retraction of ‘Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer’ by Pengying Wu et al., Nanoscale, 2019, 11, 19520–19528, https://doi.org/10.1039/C9NR05791A.

Nanoscale

Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer

Abstract

Associated articles

Article information

Download Citation

Permissions

Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer

Social activity

Search articles by author

Spotlight

Advertisements